WBA Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | Minnix Lanesha | officer: EVP and Global CLO | 0 | D | 0 | 0.00 | 0.00 | |
| 2024-04-11 | Bhandari Inderpal S | director | 3,000 | P-Purchase | A | 3,000 | 18.05 | 54,150.00 |
| 2024-04-02 | Mahajan Manmohan | officer: EVP and Global CFO | 166,969 | P-Purchase | A | 6,000 | 19.38 | 116,280.00 |
| 2024-03-18 | Langowksi Mary | officer: EVP, President U.S. Healthcare | 0 | D | 0 | 0.00 | 0.00 | |
| 2024-03-11 | Burger Elizabeth | officer: EVP, Global Chief HR Officer | 0 | D | 0 | 0.00 | 0.00 | |
| 2024-03-01 | Heckman Todd | officer: SVP, Global Controller and CAO | 41,164 | A-Award | A | 12,541 | 0.00 | 0.00 |
| 2024-03-01 | Fabbri Beth Amber L. | officer: Chief Corp. Affairs Officer | 52,822 | A-Award | A | 14,052 | 0.00 | 0.00 |
| 2024-03-01 | Brown Tracey D | officer: EVP, Pres., Walgreens Retail | 168,275 | A-Award | A | 11,219 | 0.00 | 0.00 |
| 2024-03-01 | Mahajan Manmohan | officer: EVP and Global CFO | 160,969 | A-Award | A | 101,874 | 0.00 | 0.00 |
| 2024-01-25 | Fabbri Beth Amber L. | officer: Chief Corp. Affairs Officer | 38,341 | D | 0 | 0.00 | 0.00 | |
| 2024-01-29 | JARRETT VALERIE B | director | 4,456 | P-Purchase | A | 4,456 | 22.44 | 99,993.00 |
| 2024-01-25 | Huffines Robert Luther | director | 427.96 | A-Award | A | 427.96 | 0.00 | 0.00 |
| 2024-01-25 | Huffines Robert Luther | director | 0 | D | 0 | 0.00 | 0.00 | |
| 2024-01-25 | Murphy Dominic | director | 75,352.97 | A-Award | A | 665.71 | 0.00 | 0.00 |
| 2024-01-25 | JARRETT VALERIE B | director | 30,633.65 | A-Award | A | 1,081.78 | 0.00 | 0.00 |
| 2024-01-25 | Lederer John Anthony | director | 65,252.62 | A-Award | A | 1,298.14 | 0.00 | 0.00 |
| 2024-01-16 | SCHLICHTING NANCY M | director | 0 | S-Sale | D | 15,209 | 23.05 | 350,567.00 |
| 2024-01-05 | WENTWORTH TIMOTHY C | director, officer: Chief Executive Officer | 585,122 | P-Purchase | A | 10,000 | 24.22 | 242,220.00 |
| 2023-11-10 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 73,929 | S-Sale | D | 1,000 | 20.45 | 20,450.00 |
| 2023-11-01 | WENTWORTH TIMOTHY C | director, officer: Chief Executive Officer | 562,324 | A-Award | A | 562,324 | 0.00 | 0.00 |
| 2023-11-01 | Sample Neal J. | officer: EVP, Chief Information Officer | 193,767 | A-Award | A | 46,860 | 0.00 | 0.00 |
| 2023-11-01 | Sample Neal J. | officer: EVP, Chief Information Officer | 146,907 | A-Award | A | 146,907 | 0.00 | 0.00 |
| 2023-10-30 | Sample Neal J. | officer: EVP, Chief Information Officer | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-11-01 | May Holly | officer: EVP, Global Chief HR Officer | 192,920 | A-Award | A | 118,557 | 0.00 | 0.00 |
| 2023-11-01 | May Holly | officer: EVP, Global Chief HR Officer | 191,906 | F-InKind | D | 1,014 | 21.08 | 21,375.00 |
| 2023-11-01 | May Holly | officer: EVP, Global Chief HR Officer | 188,829 | F-InKind | D | 3,077 | 21.08 | 64,863.00 |
| 2023-11-01 | Mahajan Manmohan | officer: SVP and Interim Global CFO | 60,039 | A-Award | A | 35,145 | 0.00 | 0.00 |
| 2023-11-01 | Mahajan Manmohan | officer: SVP and Interim Global CFO | 59,765 | F-InKind | D | 274 | 21.08 | 5,776.00 |
| 2023-11-01 | Mahajan Manmohan | officer: SVP and Interim Global CFO | 59,126 | F-InKind | D | 639 | 21.08 | 13,470.00 |
| 2023-11-01 | Mahajan Manmohan | officer: SVP and Interim Global CFO | 57,609 | F-InKind | D | 1,517 | 21.08 | 31,978.00 |
| 2023-11-01 | Heckman Todd | officer: Interim Global Controller | 28,613 | A-Award | A | 16,401 | 0.00 | 0.00 |
| 2023-11-01 | Heckman Todd | officer: Interim Global Controller | 28,439 | F-InKind | D | 174 | 21.08 | 3,668.00 |
| 2023-11-01 | Heckman Todd | officer: Interim Global Controller | 28,242 | F-InKind | D | 197 | 21.08 | 4,153.00 |
| 2023-11-01 | Heckman Todd | officer: Interim Global Controller | 27,774 | F-InKind | D | 468 | 21.08 | 9,865.00 |
| 2023-11-01 | Gray Danielle | officer: EVP and Global CLO | 215,059 | A-Award | A | 134,021 | 0.00 | 0.00 |
| 2023-11-01 | Gray Danielle | officer: EVP and Global CLO | 213,768 | F-InKind | D | 1,291 | 21.08 | 27,214.00 |
| 2023-11-01 | Gray Danielle | officer: EVP and Global CLO | 210,301 | F-InKind | D | 3,467 | 21.08 | 73,084.00 |
| 2023-11-01 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 76,307 | A-Award | A | 46,860 | 0.00 | 0.00 |
| 2023-11-01 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 76,063 | F-InKind | D | 244 | 21.08 | 5,144.00 |
| 2023-11-01 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 75,866 | F-InKind | D | 197 | 21.08 | 4,153.00 |
| 2023-11-01 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 74,929 | F-InKind | D | 937 | 21.08 | 19,752.00 |
| 2023-11-01 | DRISCOLL JOHN PATRICK | officer: EVP, Pres. U.S. Healthcare | 277,929 | A-Award | A | 217,901 | 0.00 | 0.00 |
| 2023-11-01 | DRISCOLL JOHN PATRICK | officer: EVP, Pres. U.S. Healthcare | 272,204 | F-InKind | D | 5,725 | 21.08 | 120,683.00 |
| 2023-11-01 | Ban Kevin M. | officer: EVP, Chief Medical Officer | 117,388 | A-Award | A | 84,349 | 0.00 | 0.00 |
| 2023-11-01 | Ban Kevin M. | officer: EVP, Chief Medical Officer | 116,992 | F-InKind | D | 396 | 21.08 | 8,348.00 |
| 2023-11-01 | Ban Kevin M. | officer: EVP, Chief Medical Officer | 116,671 | F-InKind | D | 321 | 21.08 | 6,767.00 |
| 2023-11-01 | Ban Kevin M. | officer: EVP, Chief Medical Officer | 113,930 | F-InKind | D | 2,741 | 21.08 | 57,780.00 |
| 2023-11-01 | Brown Tracey D | officer: EVP, Pres., Walgreens Retail | 156,280 | A-Award | A | 117,151 | 0.00 | 0.00 |
| 2023-11-01 | Brown Tracey D | officer: EVP, Pres., Walgreens Retail | 155,267 | F-InKind | D | 1,013 | 21.08 | 21,354.00 |
| 2023-11-01 | Brown Tracey D | officer: EVP, Pres., Walgreens Retail | 152,243 | F-InKind | D | 3,024 | 21.08 | 63,746.00 |
| 2023-11-01 | SCHLICHTING NANCY M | director | 15,209 | A-Award | A | 9,694 | 0.00 | 0.00 |
| 2023-11-01 | Polen Thomas E Jr | director | 1,696 | A-Award | A | 1,696 | 0.00 | 0.00 |
| 2023-11-01 | Polen Thomas E Jr | director | 727.1 | A-Award | A | 727.1 | 0.00 | 0.00 |
| 2023-11-01 | Murphy Dominic | director | 73,155.87 | A-Award | A | 9,694.62 | 0.00 | 0.00 |
| 2023-11-01 | Lederer John Anthony | director | 62,643.16 | A-Award | A | 9,694.62 | 0.00 | 0.00 |
| 2023-11-01 | JARRETT VALERIE B | director | 28,945.93 | A-Award | A | 9,694.62 | 0.00 | 0.00 |
| 2023-11-01 | Hanson Bryan C | director | 9,694 | A-Award | A | 9,694 | 0.00 | 0.00 |
| 2023-11-01 | GRAHAM GINGER L | director | 67,100.11 | A-Award | A | 8,078.85 | 0.00 | 0.00 |
| 2023-11-01 | Bhandari Inderpal S | director | 10,184.09 | A-Award | A | 9,694.62 | 0.00 | 0.00 |
| 2023-11-01 | Babiak Janice M. | director | 55,095.76 | A-Award | A | 9,694.62 | 0.00 | 0.00 |
| 2023-11-01 | Barra Ornella | officer: Chief Operating Officer, Int'l | 628,798 | A-Award | A | 257,732 | 0.00 | 0.00 |
| 2023-11-01 | Barra Ornella | officer: Chief Operating Officer, Int'l | 622,563 | F-InKind | D | 6,235 | 21.08 | 131,434.00 |
| 2023-10-23 | WENTWORTH TIMOTHY C | director, officer: Chief Executive Officer | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-10-26 | JARRETT VALERIE B | director | 19,251.31 | A-Award | A | 1,152.07 | 0.00 | 0.00 |
| 2023-10-26 | Murphy Dominic | director | 63,461.25 | A-Award | A | 1,152.07 | 0.00 | 0.00 |
| 2023-10-26 | Lederer John Anthony | director | 52,948.54 | A-Award | A | 1,382.49 | 0.00 | 0.00 |
| 2023-10-25 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 30,636 | A-Award | A | 4,057 | 0.00 | 0.00 |
| 2023-10-25 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 29,447 | F-InKind | D | 1,189 | 21.37 | 25,409.00 |
| 2023-10-25 | Heckman Todd | officer: Interim Global Controller | 13,062 | A-Award | A | 2,898 | 0.00 | 0.00 |
| 2023-10-25 | Heckman Todd | officer: Interim Global Controller | 12,213 | F-InKind | D | 849 | 21.37 | 18,143.00 |
| 2023-10-25 | Mahajan Manmohan | officer: SVP and Interim Global CFO | 26,083 | A-Award | A | 4,057 | 0.00 | 0.00 |
| 2023-10-25 | Mahajan Manmohan | officer: SVP and Interim Global CFO | 24,894 | F-InKind | D | 1,189 | 21.37 | 25,409.00 |
| 2023-10-25 | Ban Kevin M. | officer: EVP, Chief Medical Officer | 34,972 | A-Award | A | 5,796 | 0.00 | 0.00 |
| 2023-10-25 | Ban Kevin M. | officer: EVP, Chief Medical Officer | 33,039 | F-InKind | D | 1,933 | 21.37 | 41,308.00 |
| 2023-10-25 | Barra Ornella | officer: Chief Operating Officer, Int'l | 378,155 | A-Award | A | 52,167 | 0.00 | 0.00 |
| 2023-10-25 | Barra Ornella | officer: Chief Operating Officer, Int'l | 371,066 | F-InKind | D | 7,089 | 21.37 | 151,492.00 |
| 2023-10-25 | Pessina Stefano | director, 10 percent owner, officer: Executive Chairman of Board | 1,057,265 | A-Award | A | 207,039 | 0.00 | 0.00 |
| 2023-07-27 | Heckman Todd | officer: Interim Global Controller | 10,044 | D | 0 | 0.00 | 0.00 | |
| 2019-11-01 | Heckman Todd | officer: Interim Global Controller | 0 | D | 7,335 | 82.46 | 604,844.00 | |
| 2023-07-27 | Heckman Todd | officer: Interim Global Controller | 0 | D | 8,831 | 67.01 | 591,765.00 | |
| 2023-07-27 | Heckman Todd | officer: Interim Global Controller | 0 | D | 6,172 | 79.90 | 493,143.00 | |
| 2023-07-27 | Heckman Todd | officer: Interim Global Controller | 0 | D | 7,550 | 57.38 | 433,219.00 | |
| 2023-07-27 | Heckman Todd | officer: Interim Global Controller | 0 | D | 5,160 | 34.04 | 175,646.00 | |
| 2023-07-27 | Heckman Todd | officer: Interim Global Controller | 0 | D | 11,385 | 47.32 | 538,738.00 | |
| 2023-07-11 | Polen Thomas E Jr | director | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-07-12 | Murphy Dominic | director | 60,961.95 | A-Award | A | 824.54 | 0.00 | 0.00 |
| 2023-07-12 | JARRETT VALERIE B | director | 17,707.91 | A-Award | A | 824.54 | 0.00 | 0.00 |
| 2023-07-12 | Lederer John Anthony | director | 50,451.11 | A-Award | A | 989.45 | 0.00 | 0.00 |
| 2023-06-30 | DRISCOLL JOHN PATRICK | officer: EVP, Pres. U.S. Healthcare | 59,050 | P-Purchase | A | 5,172 | 28.42 | 146,984.00 |
| 2023-06-01 | Gray Danielle | officer: EVP and Global CLO | 79,645 | A-Award | A | 32,982 | 0.00 | 0.00 |
| 2023-06-01 | May Holly | officer: EVP, Global Chief HR Officer | 73,078 | A-Award | A | 32,982 | 0.00 | 0.00 |
| 2023-05-01 | Kehoe James | officer: EVP and Global CFO | 268,403 | F-InKind | D | 6,020 | 35.25 | 212,205.00 |
| 2023-04-20 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 26,202.3 | D | 0 | 0.00 | 0.00 | |
| 2016-11-01 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 0 | D | 3,227 | 60.52 | 195,298.00 | |
| 2017-11-01 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 0 | D | 2,552 | 64.22 | 163,889.00 | |
| 2018-11-01 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 0 | D | 2,742 | 84.68 | 232,193.00 | |
| 2019-11-01 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 0 | D | 3,814 | 82.46 | 314,502.00 | |
| 2023-04-20 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 0 | D | 7,065 | 67.01 | 473,426.00 | |
| 2023-04-20 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 0 | D | 9,073 | 79.90 | 724,933.00 | |
| 2023-04-20 | Gates Richard P. | officer: SVP, Chief Pharmacy Officer | 0 | D | 9,191 | 57.38 | 527,380.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
